Overview

Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects

Status:
Completed
Trial end date:
2018-08-22
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the pharmacokinetics (PK) and safety of multiple doses of PBI-4050 combined with midazolam in healthy adult subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Liminal BioSciences Ltd.
ProMetic Pharma SMT Limited
Collaborator:
Celerion
Treatments:
Midazolam